- Home
- BIGC vs CMRX Comparison
BIGC vs CMRX Comparison
Compare BIGC & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIGC
- CMRX
- Stock Information
- Founded
- BIGC 2009
- CMRX 2000
- Country
- BIGC United States
- CMRX United States
- Employees
- BIGC N/A
- CMRX N/A
- Industry
- BIGC Computer Software: Prepackaged Software
- CMRX Biotechnology: Pharmaceutical Preparations
- Sector
- BIGC Technology
- CMRX Health Care
- Exchange
- BIGC Nasdaq
- CMRX Nasdaq
- Market Cap
- BIGC 477.3M
- CMRX 394.1M
- IPO Year
- BIGC 2020
- CMRX 2013
- Fundamental
- Price
- BIGC $6.23
- CMRX $5.15
- Analyst Decision
- BIGC Hold
- CMRX Strong Buy
- Analyst Count
- BIGC 8
- CMRX 2
- Target Price
- BIGC $8.13
- CMRX $8.50
- AVG Volume (30 Days)
- BIGC 1.0M
- CMRX 1.7M
- Earning Date
- BIGC 02-20-2025
- CMRX 03-07-2025
- Dividend Yield
- BIGC N/A
- CMRX N/A
- EPS Growth
- BIGC N/A
- CMRX N/A
- EPS
- BIGC N/A
- CMRX N/A
- Revenue
- BIGC $332,927,000.00
- CMRX $159,000.00
- Revenue This Year
- BIGC $9.70
- CMRX N/A
- Revenue Next Year
- BIGC $5.38
- CMRX $1,690.28
- P/E Ratio
- BIGC N/A
- CMRX N/A
- Revenue Growth
- BIGC 7.61
- CMRX N/A
- 52 Week Low
- BIGC $5.13
- CMRX $0.75
- 52 Week High
- BIGC $8.60
- CMRX $5.53
- Technical
- Relative Strength Index (RSI)
- BIGC 42.21
- CMRX 76.25
- Support Level
- BIGC $6.12
- CMRX $3.94
- Resistance Level
- BIGC $7.50
- CMRX $5.53
- Average True Range (ATR)
- BIGC 0.38
- CMRX 0.30
- MACD
- BIGC -0.04
- CMRX 0.07
- Stochastic Oscillator
- BIGC 23.95
- CMRX 78.29
About BIGC BigCommerce Holdings Inc. Series 1
BigCommerce Holdings Inc is engaged in offering Software-as-a-service (SaaS) e-commerce platform. The company's SaaS platform engages in the creation of online stores by delivering a combination of ease-of-use, enterprise functionality, and flexibility. It powers both the customers' branded ecommerce stores and their cross-channel connections to popular online marketplaces, social networks, and offline point-of-sale systems. The group operates in a single segment covering geographical areas of Americas-U.S.; Americas-other; EMEA; and APAC, of which majority of revenue is generated from Americas-U.S.
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.